Cours Inovio Pharmaceuticals Inc Nyse
Actions
INO
US45773H2013
Recherche biotechnologique et médicale
CA 2024 * | 538 k 488 k | CA 2025 * | 8,82 M 8 M | Capitalisation | 294 M 267 M |
---|---|---|---|---|---|
Résultat net 2024 * | -114 M -103 M | Résultat net 2025 * | -108 M -97,89 M | VE / CA 2024 * | 547 x |
Trésorerie nette 2024 * | - 0 | Trésorerie nette 2025 * | - 0 | VE / CA 2025 * | 33,4 x |
PER 2024 * |
-2,67
x | PER 2025 * |
-3,4
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 98,51% |
Dernier transcript sur Inovio Pharmaceuticals Inc
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Jacqueline Shea
CEO | Chief Executive Officer | 58 | 25/03/19 |
Peter Kies
DFI | Director of Finance/CFO | 60 | 01/06/02 |
Chief Tech/Sci/R&D Officer | - | 01/02/07 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Simon Benito
CHM | Chairman | 79 | 01/12/03 |
Lota Zoth
BRD | Director/Board Member | 64 | 01/01/18 |
Jay Shepard
BRD | Director/Board Member | 65 | 15/01/20 |
Varia. 1 janv. | Capi. | |
---|---|---|
+29,03% | 48,16 Md | |
-0,10% | 41,73 Md | |
+43,45% | 41,03 Md | |
-5,26% | 28,77 Md | |
+11,48% | 25,59 Md | |
-22,74% | 18,96 Md | |
+9,06% | 12,92 Md | |
+30,01% | 12,03 Md | |
-1,51% | 11,77 Md |